New approaches for detecting thresholds of human nephrotoxicity using cadmium as an example

Environmental Health Perspectives

Volumn 106, Issue 5, 1998, Pages 227-230

  Mueller, Patricia W ^a   Price, Robert G ^b   Finn, William F ^c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Biomarkers; Cadmium; Human; Kidneys; Lead; Mercury; Metals; Nephrotoxicity; Solvents

Indexed keywords

CADMIUM; COLLAGEN; CYTOKINE; GLYCOPROTEIN; GROWTH FACTOR; LIPID; NUCLEIC ACID; PROTEOGLYCAN; TRANSCRIPTION FACTOR;

APOPTOSIS; CARDIOVASCULAR DISEASE; CELL CYCLE; CELL DEATH; CELL GROWTH; CELL PROLIFERATION; CELL REGENERATION; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; EARLY DIAGNOSIS; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENETIC PREDISPOSITION; HUMAN; HYPERTENSION; KIDNEY DISEASE; NEPHROTOXICITY; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; PROTO ONCOGENE; RISK FACTOR; SHORT SURVEY;

EID: 0031846115     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.98106227     Document Type: Short Survey

References (39)

1. National Research Council. Biologic Markers in Urinary Toxicology. Washington, DC:National Academy Press, 1995.
2. Jerry B. Hook, ed. Toxicology of the Kidney. New York:Raven Press, 1981.
3. Mueller PW, Lash L, Price RG, Stolte H, Gelpi E, Maack T, Berndt WO. Urinary biomarkers to detect significant effects of environmental and occupational exposure to nephrotoxins: I. Categories of tests for detecting effects of nephrotoxins. Renal Failure 19:505-521(1997).
4. Mueller PW, Smith SJ, Steinberg KK, Thun MJ. Chronic renal tubular effects in relation to urine cadmium levels. Nephron 52:45-54 (1989).
5. Mueller PW, Paschal DC, Hammel RR, Klincewicz SL, MacNeil ML, Spierto B, Steinberg KK. Chronic renal effects in three studies of men and women occupationally exposed to cadmium. Arch Environ Contam Toxicol 23:125-136 (1992).
6. Mueller PW. Detecting the renal effects of cadmium toxicity. Clin Chem 39:743-745 (1993).
7. Cardenas A, Roels H, Bernard AM, Barbon R, Buchet JP, Lauwerys RR, Rosello J, Hotter G, Mutti A, Franchini I, et al. Markers of early real changes induced by industrial pollutants. I. Application to workers exposed to mercury vapour. Br J Ind Med 50:17-27 (1993).
8. Cardenas A, Roels H, Bernard AM, Barbon R, Buchet JP, Lauwerys RR, Rosello J, Ramis I, Mutti A, Franchini I, et al. Markers of early renal changes induced by industrial pollutants. II. Application to workers exposed to lead. Br J Ind Med 50:28-36 (1993).
9. Roels H, Bernard AM, Cardenas A, Buchet JP, Lauwerys RR, Hotter G, Ramis I, Mutti A, Franchini I, Bundschuh I, et al. Markers of early renal changes induced by industrial pollutants. III. Application to workers exposed to cadmium. Br J Ind Med 50:37-48 (1993).
10. Lauwerys RR, Bernard AM, Roels HA, Buchet JP. Cadmium: exposure markers as predictors of nephrotoxic effects. Clin Chem 40:1391-1394 (1994).
11. Bernard A, Stolte H, DeBroe M, Mueller P, Mason H, Lash L, Fowler B, Urinary biomarkers to detect significant effects of environmental and occupational exposure to nephrotoxins: IV. Current information on interpreting the health Implications of tests. Renal Failure 19:553-566 (1997).
12. Järup L, Carlsson MD, Elinder CG, Hellström L, Persson B, Schütz A. Enzymuria in a population living near a cadmium battery plant. Occup Environ Med 52:770-772 (1995).
13. Sarasua SM, McGeehin MA, Stallings FL, Terracciano GJ, Amler RW, Logue JN, Fox JM. Biologic Indicators of Exposure to Cadmium and Lead: Palmerton, Pennsylvania, Part II. Atlanta,GA:Agancy for Toxic Substances and Disease Registry, 1995.
14. Lauwerys R, Roels H, Bernard A, Buchet JP. Renal response to cadmium in a population living in a non-ferrous smelter area in Belgium. Int Arch Occup Environ Health 45:271-274 (1980).
15. 1 microglobulin as an indicator protein of renal tubular dysfunction caused by environmental cadmium exposure. J Appl Toxicol 6:171-178 (1986).
16. Chia KS, Ong CN, Ong HY, Endo G. Renal tubular function of workers exposed to low levels of cadmium. Br J Ind Med 46:165-170 (1989).
17. Lauwerys RR, Buchet JP, Roels HA, Brouwers J, Stanescu D, Epidemiologies survey of workers exposed to cadmium. Arch Environ Health 28:145-148 (1974).
18. Järup L, Elinder G. Incidence of renal stones among cadmium-exposed battery workers. Br J Ind Med 50:598-602 (1993).
19. Aoshima K, Kawanishi Y, Fan J-J, Cai Y-Q, Katoh T, Teranishi H, Kasuya M. Cross-sectional assessment of renal function in the inhabitants of a cadmium-polluted area. Ann Clin Lab Sci 25:493-503 (1995).
20. Nishijo M, Nakagawa H, Morikawa Y, Tabata M, Senma M, Miura K, Takahara H, Kawano S, Nishi M, Mizukoshi K, et al. Mortality of inhabitants in an area polluted by cadmium: 15 year follow up. Occup Environ Med 52:181-184 (1995).
21. Mueller PW, Hall WD, Caudill SP, MacNeil ML, Arepally A. An in-depth examination of the excretion of albumin and other sensitive markers of renal damage in mild hypertension. Am J Hypertens 8:1072-1082 (1995).
22. Goyer R, Eknoyan G, DeBroe ME, Buckalew V. Mutti A, Porter G, Morin JP. Urinary biomarkers to detect significant effects of environmental and occupational exposure to nephrotoxins: II. Nephrotoxins of significant frequency and economic impact Renal Failure 19:523-534 (1997).
23. Roels H, Djubgang J, Buchet JP, Bernard A, Lauwerys R. Evolution of cadmium-induced renal dysfunction in workers removed from exposure. Scand J Work Environ Health 8:191-200 (1982).
24. Roels HA, Lauwerys RR, Buchet JP, Bernard AM, Vos A, Oversteyns M. Health signficance of cadmium- induced renal dysfunction: a five-year follow up. Br J Ind Med 46:755-764 (1989).
25. Roels HA, Lauwerys RR, Bernard AM, Buchet JP, Vos A, Oversteyns M. Assessment of the filtration reserve capacity of the kidney in workers exposed to cadmium. Br J Ind Med 48:365-374 (1991).
26. Scherberich JE, Wolf G. Disintegration and recovery of kidney membrane proteins: consequence of acute and chronic renal failure. Kidney Int 47(suppl):S52-S57 (1994).
27. Ellis BG, Price RG, Topham JC. The effect of tubular damage by mercuric chloride on kidney function and some urinary enzymes in the dog. Chem Bio Interact 7:101-113 (1973).
28. Prescott LF, Ansari S. The effects of repeated administration of mercuric chloride on exfoliation of renal tubular cells and urinary glutamic-oxaloacetic transaminase activity in the rat. Toxicol Appl Pharmacol 14:97-107 (1969).
29. Bulger RE, Dobyan DC. Proliferate lesions found in rat kidney after a single dose of cisplatin. J Natl Cancer Inst 73:1235-1239 (1984).
30. Goren MP, Wright RK, Horowitz ME. Cumulative renal tubular damage associated with cisplatin nephrotoxicity. Cancer Chemother Pharmacol 18:69-73 (1986).
31. Goren MP, Wright RK, Horowitz ME, Crom WR, Meyer WH. Urinary N-acetyl-β-D-glucosaminidase and serum creatinine concentrations predict impaired excretion of methotrexate. J Clin Oncol 5:804-810 (1987).
32. Finn WF, Nolan C, Lash LH, Lorenzon G, Manley SE, Safirstein R. Urinary biomarkers to detect significant effects of environmental and occupational exposure to nephrotoxins: VI. Future research needs. Renal Failure 19:575-594 (1997).
33. Safirstein R, Price PM, Saggi SJ, Harris RC. Changes in gene expression after temporary renal ischemia. Kidney Int 37:1515-1521 (1990).
34. ter Meulen CG, Bilo HJ, van Kamp GJ, Gans RO, Donker AJ. Urinary epidermal growth factor excretion is correlated to renal function loss per se and not to the degree of diabetic renal failure. Neth J Med 44:12-17 (1994).
35. Kawaguchi M, Kamiya Y, Ito J, Fujii T, Hayakawa F, Sakuma N, Fujinami T. Excretion of urinary epidermal growth factor in non-insulin dependent diabetes mellitus. Life Sci 52:1181-1186 (1993).
36. Campbell JA, Corrigall AV, Guy A, Kirsch RE. Immunohistologic localization of alpha, mu, and pi class glutathione S-transferases in human tissues. Cancer 67:1608-1613 (1991).
37. Sundberg A, Appelkvist E-L, Dallner G, Nilsson R. Glutathione transferases in the urine: sensitive methods for detection of kidney damage induced by nephrotoxic agents in humans. Environ Health Perspect 102(suppl 3):293-296 (1994).
38. Sundberg AG, Appelkvist EL, Backman L, Dallner G. Urinary pi-class glutathione transferase as an indicator of tubular damage in the human kidney. Nephron 67:308-316 (1994).
39. Mueller PW, Price RG, Porter GA. Overview: Proceedings of the Joint US/EU Workshop: Urinary biomarkers to detect significant erffects of environmental and occupational exposure to nephrotoxins. Renal Failure 19:501-504 (1997).